Skip to content

An Observational Study Based on Endometrial Cancer Risk Screening Model

An Observational Study Based on Endometrial Cancer Risk Screening Model

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05634798
Enrollment
2000
Registered
2022-12-02
Start date
2022-12-01
Completion date
2023-12-01
Last updated
2022-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometrial Neoplasms

Brief summary

The goal of this observational study is to test the efficiency of our endometrial cancer risk screening calculator, and improve the endometrial cancer risk screening model to form a stable and reliable non-invasive auxiliary diagnostic tool with high sensitivity and specificity in healthy women.The main question it aims to answer is: ·the efficiency of our endometrial cancer risk screening calculator Participants will be collected demographic information, as well as ultrasound, blood routine test and other test results, which will be entered into the endometrial cancer risk screening calculator to obtain high-risk or low-risk prediction results.

Interventions

OTHERno intervention

There is no intervention in this study.

Sponsors

Peking Union Medical College Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

1. Age: 18-70; 2. The annual update of questionnaire information required by the calculator can be completed, and the gynecological examination, gynecological B-ultrasound and blood test can be evaluated once a year, and the follow-up can be at least 1 year; The patient or family members can understand the research scheme and are willing to participate in the study, and provide e-book informed consent.

Exclusion criteria

1. Endometrial cancer or precancerous lesions have been diagnosed; 2. Previous or current malignant tumor, currently receiving radiotherapy and chemotherapy, endocrine, targeted and immunotherapy; 3. History of endometrial resection or total hysterectomy; 4. Pregnant or lactating women; 5. The patient or family member could not understand the conditions and objectives of this study.

Design outcomes

Primary

MeasureTime frameDescription
Obtained endometrial pathological specimens due to any factors1 yearThe study object was obtained endometrial pathological specimen within one year due to any factor.
No endometrial cancer or precancerous lesions1 yearThe study object did not show B-ultrasound and clinical symptoms which indicate endometrial cancer or precancerous lesions.

Countries

China

Contacts

Primary ContactShu Wang, Doctor
wangshu219@hotmail.com008613671246680

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026